A multi-centre, pragmatic, randomised controlled trial of comparing enhanced Acceptance and Commitment Therapy (plus) added to usual aftercare, versus usual aftercare only

Queen Mary University of London0 sites344 target enrollmentDecember 9, 2019

Overview

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38566197/ (added 03/04/2024)

Registry

who.int

Start Date

December 9, 2019

End Date

April 30, 2025

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•Current inclusion criteria as of 28/11/2023:
•1\. Within 24 months of having completed cancer treatment, (or about to complete) with curative intent for breast cancer, lower gastro\-intestinal cancer, urological cancer, a haematological cancer, head and neck cancer, and any other common cancer with good survival
•2\. Aged 18 years or over
•3\. Participant’s GP practice falls within a participating IAPT service catchment, or if other psychological service provider, participant resides within their catchment area
•4\. Ability to give informed consent
•5\. Sufficient fluency in spoken English to be able to participate in a talking\-based therapy delivered in English
•6\. With a score of 78 or less on the Functional Assessment of Cancer Therapy – General (FACT\-G)
•Previous inclusion criteria:
•1\. Within 24 months of having completed cancer treatment, (or about to complete) with curative intent for breast cancer, colorectal cancer, prostate cancer, a haematological cancer, head and neck cancer, and any other common cancer with good survival
•2\. Aged 18 years or over

•Current exclusion criteria as of 28/11/2023:
•1\. Will not have not completed their cancer treatment by the commencement of the trial (excepting those receiving long\-term, ongoing maintenance treatment e.g. androgen suppression therapy in urological cancer)
•2\. Receiving palliative or terminal care
•3\. Currently receiving another psychological intervention (NB participants taking antidepressants or anxiolytic drugs remain eligible)
•4\. Other serious co\-morbid condition which would make it difficult for the participant to receive a talking\-based one\-to one intervention
•5\. Require urgent psychiatric or clinical psychology assessment
•Previous exclusion criteria:
•1\. Will not have not completed their cancer treatment by the commencement of the trial (excepting those receiving long\-term, ongoing maintenance treatment e.g. androgen suppression therapy in prostate cancer)
•2\. Receiving palliative or terminal care
•3\. Currently receiving another psychological intervention (NB participants taking antidepressants or anxiolytic drugs remain eligible)